Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes.

scientific article published on 13 July 2015

Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2015/369758
P932PMC publication ID4515498
P698PubMed publication ID26247037
P5875ResearchGate publication ID280870479

P50authorMichal DubskyQ64852759
P2093author name stringEdward B Jude
Alexandra Jirkovská
Vladimíra Fejfarová
Andrea Němcová
Robert Bém
Veronika Wosková
Libuše Pagáčová
P2860cites workActivated protein C resistance in patients with peripheral vascular disease.Q54120223
Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial diseaseQ56983670
C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patientsQ78224334
The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control studyQ80435699
Interference of IP-10 expression inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in carotid artery: a new insight in the prevention of restenosisQ84785522
Activated protein C resistance testing for factor V LeidenQ85706834
Clinical profile, common thrombophilia markers and risk factors in 85 young Indian patients with arterial thrombosisQ86965549
Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysisQ28743107
The insulin-like growth factor axis: A review of atherosclerosis and restenosisQ33832995
Risk assessment for recurrent venous thrombosisQ34153343
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).Q34586454
Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.Q34986363
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trialQ35069850
Epidemiology of Prothrombin G20210A Mutation in the Mediterranean RegionQ35640739
Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studiesQ35777069
Hyperhomocysteinemia and venous thromboembolism.Q36616124
Review article: Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants.Q37578743
Laboratory investigation of thrombophilia: the good, the bad, and the uglyQ37655851
Diagnosis and management of heritable thrombophilias.Q38230831
Association between MTHFR C677T polymorphism and venous thromboembolism risk in the Chinese population: a meta-analysis of 24 case-controlled studiesQ38242424
Genetics in thrombophilia. An updateQ38281345
Extensive arterial thrombosis in a patient with factor V Leiden mutationQ43111702
Risk factors for thrombophilia in young adults presenting with thrombosisQ43235975
PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcomeQ43607196
An Association of Autoantibody Status and Serum Cytokine Levels in Type 1 DiabetesQ44418703
Infrapopliteal drug-eluting stents for chronic limb ischemia.Q48013476
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P921main subjectangioplastyQ539795
P304page(s)369758
P577publication date2015-07-13
P1433published inJournal of Diabetes ResearchQ26841822
P1476titleImpact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes
P478volume2015